Rockbridge Investment Management, Lcc Moderna, Inc. Transaction History

Rockbridge Investment Management, Lcc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$69.51 - $104.43 $3,823 - $5,743	-55 Reduced 84.62%	10 $995,000
Q3 2022 May 28, 2024	SELL	$118.07 - $194.18 $1,180 - $1,941	-10 Closed	0 $0
Q2 2022 May 28, 2024	SELL	$117.13 - $176.59 $5,270 - $7,946	-45 Reduced 81.82%	10 $1,000
Q1 2022 May 28, 2024	BUY	$126.46 - $235.05 $6,955 - $12,927	55 New	55 $9,000
Q4 2021 Feb 14, 2022	BUY	$225.82 - $368.51 $10,161 - $16,582	45 Added 225.0%	65 $17,000
Q3 2021 Nov 12, 2021	BUY	$221.9 - $484.47 $4,438 - $9,689	20 New	20 $7,000
Q2 2021 Aug 05, 2021	SELL	$129.91 - $234.98 $15,978 - $28,902	-123 Closed	0 $0
Q4 2020 Mar 04, 2021	BUY	$65.74 - $169.86 $8,086 - $20,892	123 New	123 $13,000

953

240M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.8B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Rockbridge Investment Management, Lcc, based on Form 13F filings with the SEC.

Stay updated on Rockbridge Investment Management, Lcc with notifications on news.